Moscow Officials See No Risks in AstraZeneca Plant Construction

Moscow's investment department head Anatoly Garbuzov publicly endorsed the AstraZeneca pharmaceutical plant project, dismissing any risks. This signals continued foreign investment in Russia's pharma sector despite geopolitical tensions. The statement is routine reassurance, with no new developments or deviations from prior policy.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works